Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Shin EC, Park SH, Nascimbeni M, Major M, Caggiari L, de Re V, Feinstone SM, Rice CM, Rehermann B.

J Virol. 2013 Apr;87(8):4772-7. doi: 10.1128/JVI.03122-12. Epub 2013 Feb 6.

2.

Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: a relevant ex vivo model of liver infection.

Lagaye S, Shen H, Saunier B, Nascimbeni M, Gaston J, Bourdoncle P, Hannoun L, Massault PP, Vallet-Pichard A, Mallet V, Pol S.

Hepatology. 2012 Sep;56(3):861-72. doi: 10.1002/hep.25738. Epub 2012 Jul 12.

PMID:
22454196
3.

Recruitment and interaction of human dendritic and T cells in autologous liver slices experimentally infected with HCV produced in cell culture.

Nascimbeni M, Bourdoncle P, Penna C, Saunier B.

J Immunol Methods. 2012 Apr 30;378(1-2):51-5. doi: 10.1016/j.jim.2012.02.003. Epub 2012 Feb 12.

PMID:
22349126
4.

Delayed induction, not impaired recruitment, of specific CD8⁺ T cells causes the late onset of acute hepatitis C.

Shin EC, Park SH, Demino M, Nascimbeni M, Mihalik K, Major M, Veerapu NS, Heller T, Feinstone SM, Rice CM, Rehermann B.

Gastroenterology. 2011 Aug;141(2):686-95, 695.e1. doi: 10.1053/j.gastro.2011.05.006. Epub 2011 May 18.

5.

Distinct CD4+ CD8+ double-positive T cells in the blood and liver of patients during chronic hepatitis B and C.

Nascimbeni M, Pol S, Saunier B.

PLoS One. 2011;6(5):e20145. doi: 10.1371/journal.pone.0020145. Epub 2011 May 25.

6.

Human immunodeficiency virus and hepatitis C infections induce distinct immunologic imprints in peripheral mononuclear cells.

Nascimbeni M, Montange T, Law HK, Mallet V, Saunier B, Rivière Y, Pol S.

Hepatology. 2010 Jan;51(1):353. doi: 10.1002/hep.23165. No abstract available.

PMID:
20034022
7.

Plasmacytoid dendritic cells accumulate in spleens from chronically HIV-infected patients but barely participate in interferon-alpha expression.

Nascimbeni M, Perié L, Chorro L, Diocou S, Kreitmann L, Louis S, Garderet L, Fabiani B, Berger A, Schmitz J, Marie JP, Molina TJ, Pacanowski J, Viard JP, Oksenhendler E, Beq S, Abehsira-Amar O, Cheynier R, Hosmalin A.

Blood. 2009 Jun 11;113(24):6112-9. doi: 10.1182/blood-2008-07-170803. Epub 2009 Apr 14.

8.

Primary infection with simian immunodeficiency virus: plasmacytoid dendritic cell homing to lymph nodes, type I interferon, and immune suppression.

Malleret B, Manéglier B, Karlsson I, Lebon P, Nascimbeni M, Perié L, Brochard P, Delache B, Calvo J, Andrieu T, Spreux-Varoquaux O, Hosmalin A, Le Grand R, Vaslin B.

Blood. 2008 Dec 1;112(12):4598-608. doi: 10.1182/blood-2008-06-162651. Epub 2008 Sep 11.

9.

Antigen crosspresentation by human plasmacytoid dendritic cells.

Hoeffel G, Ripoche AC, Matheoud D, Nascimbeni M, Escriou N, Lebon P, Heshmati F, Guillet JG, Gannagé M, Caillat-Zucman S, Casartelli N, Schwartz O, De la Salle H, Hanau D, Hosmalin A, Marañón C.

Immunity. 2007 Sep;27(3):481-92.

10.

A role for exposed mannosylations in presentation of human therapeutic self-proteins to CD4+ T lymphocytes.

Dasgupta S, Navarrete AM, Bayry J, Delignat S, Wootla B, André S, Christophe O, Nascimbeni M, Jacquemin M, Martinez-Pomares L, Geijtenbeek TB, Moris A, Saint-Remy JM, Kazatchkine MD, Kaveri SV, Lacroix-Desmazes S.

Proc Natl Acad Sci U S A. 2007 May 22;104(21):8965-70. Epub 2007 May 14.

11.

Immunology of hepatitis B virus and hepatitis C virus infection.

Rehermann B, Nascimbeni M.

Nat Rev Immunol. 2005 Mar;5(3):215-29. Review.

PMID:
15738952
12.

Effects of antiviral therapy on the cellular immune response in acute hepatitis C.

Rahman F, Heller T, Sobao Y, Mizukoshi E, Nascimbeni M, Alter H, Herrine S, Hoofnagle J, Liang TJ, Rehermann B.

Hepatology. 2004 Jul;40(1):87-97.

PMID:
15239090
13.

Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.

Jeong SH, Qiao M, Nascimbeni M, Hu Z, Rehermann B, Murthy K, Liang TJ.

J Virol. 2004 Jul;78(13):6995-7003.

14.

Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions.

Nascimbeni M, Shin EC, Chiriboga L, Kleiner DE, Rehermann B.

Blood. 2004 Jul 15;104(2):478-86. Epub 2004 Mar 25.

15.

Determination of hepatitis B virus-specific CD8+ T-cell activity in the liver.

Nascimbeni M, Rehermann B.

Methods Mol Med. 2004;96:65-83. No abstract available.

PMID:
14762260
16.

Chronic HCV infection and the clonality of intrahepatic T cells.

Nascimbeni M, Rehermann B.

J Hepatol. 2003 May;38(5):677-80. Review. No abstract available.

PMID:
12713882
17.

Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees.

Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, Feinstone SM, Rehermann B.

J Virol. 2003 Apr;77(8):4781-93.

18.

The clearance of hepatitis C virus infection in chimpanzees may not necessarily correlate with the appearance of acquired immunity.

Thomson M, Nascimbeni M, Havert MB, Major M, Gonzales S, Alter H, Feinstone SM, Murthy KK, Rehermann B, Liang TJ.

J Virol. 2003 Jan;77(2):862-70.

19.

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection.

Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, Hoofnagle JH, Liang TJ, Alter H, Rehermann B.

J Immunol. 2002 Sep 15;169(6):3447-58.

20.

Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM.

J Virol. 2002 Jul;76(13):6586-95.

21.

Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies.

Mizukoshi E, Nascimbeni M, Blaustein JB, Mihalik K, Rice CM, Liang TJ, Feinstone SM, Rehermann B.

J Virol. 2002 Jun;76(12):6093-103.

22.

Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus.

Thomson M, Nascimbeni M, Gonzales S, Murthy KK, Rehermann B, Liang TJ.

Gastroenterology. 2001 Nov;121(5):1226-33.

PMID:
11677216
23.

Kinetics of antiviral activity and intracellular pharmacokinetics of human immunodeficiency virus type 1 protease inhibitors in tissue culture.

Nascimbeni M, Lamotte C, Peytavin G, Farinotti R, Clavel F.

Antimicrob Agents Chemother. 1999 Nov;43(11):2629-34.

24.

The replicative impairment of Vif- mutants of human immunodeficiency virus type 1 correlates with an overall defect in viral DNA synthesis.

Nascimbeni M, Bouyac M, Rey F, Spire B, Clavel F.

J Gen Virol. 1998 Aug;79 ( Pt 8):1945-50.

PMID:
9714242
25.

Phenotypically Vif- human immunodeficiency virus type 1 is produced by chronically infected restrictive cells.

Bouyac M, Rey F, Nascimbeni M, Courcoul M, Sire J, Blanc D, Clavel F, Vigne R, Spire B.

J Virol. 1997 Mar;71(3):2473-7.

Supplemental Content

Loading ...
Support Center